Sulaiman Al Habib profit up 25% to SAR 489.3 mln in Q1 2023

07/05/2023 Argaam Exclusive

View other reports

Share Price

Dr. Sulaiman Al Habib Medical Services Group (SULAIMAN ALHABIB)

Dr. Sulaiman Al Habib Medical Services Group (HMG) posted a 25% leap in Q1 2023 net profit to SAR 489.3 million, compared to SAR 390.5 million in the prior-year period.



Current Quarter Comparison (M)

Compared With The
Item Q1 2022 Q1 2023 Change‬
Revenues 1,990.86 2,306.88 15.9 %
Gross Income 658.56 783.64 19.0 %
Operating Income 422.09 510.57 21.0 %
Net Income 390.51 489.27 25.3 %
Average Shares 350.00 350.00 -
EPS (Riyals) 1.12 1.40 25.3 %

The first-quarter results were driven by a 15.87% year-on-year (YoY) rise in revenue to SAR 2.30 billion, on growth across all segments. 

 

The higher revenue was mainly driven by the growth in the hospital segment, due to an increase in the number of patients and better inpatient occupancy.

 

The pharmacy segment’s sales increase was driven also by a rise in the number of patients compared to Q1 2022. 

 

EBITDA for Q1 increased 19.65% YoY to SAR 622.80 million, leading to an EBITDA margin of 27.00% compared to 26.15% in Q1 2022. 

 

Compared to Q4 2022, net profit grew 10.8% from SAR 441.50 million, as revenue grew by 2.36%. 

 

Shareholders’ equity, no minority interest, rose to SAR 6.05 billion as of March 31, 2023, from SAR 5.48 billion a year earlier.

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.